Caraco faces class action suit in the US
29 July 2009
Becky Debens
Please Login to read the full article.
29 July 2009
Becky Debens
Caraco Pharmaceutical Laboratories, currently under US
FDA scrutiny for current good manufacturing practice (cGMP) lapses, faces a class action suit in the US for allegedly failing to make adequate disclosures during the regulatory probe. Caraco is a US subsidiary of India's
Sun Pharmaceutical...
Please Login to read the full article.
RELATED CONTENT
NEWS
- US Capitol Capsule: Senate & Supreme Court tackle issues of US patent system
- Drugs from Ranbaxy India plants banned from US until fixes confirmed
- Ranbaxy enters US consent decree and makes $500m liabilities provision
- Sun resolves US compliance at Cranbury unit but Detroit issues persist
EVENTS
Today
London
28 February 2012
Pestana Chelsea Bridge Hotel London
04 March 2012
The Marriott World Center, Orlando, Florida
JOB OF THE WEEK
Promote your vacancy here
